Watchful waiting for certain abnormal cells in the cervix
Part of Cancer, Infections, Women’s health & pregnancy clinical trials.
This trial checks whether “therapy abstention” (not treating right away) and close monitoring is safe for certain high-grade cervical cell changes. It may help some people avoid immediate procedures while still catching any progression early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your cervical biopsy shows CIN2 (a specific high-grade precancer), confirmed by pathology
- You are between 18 and 39 years old
- Your colposcopy exam was complete enough to clearly view the area where the abnormal cells sit
- You can take part through the French social security system (or be covered as a beneficiary)
- You agree to the study and to have your data used
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at better ways to manage early precancerous changes in the cervix (called high-grade lesions) without surgery. It aims to find which approaches work best for women who have not been vaccinated against HPV.
This study tests whether removing a small piece of the cervix (cone biopsy) can help diagnose hidden precancer when regular tests are unclear. It may help you get a clearer diagnosis if you have ongoing HPV or abnormal cell changes.
This study tests a new questionnaire that may help doctors better identify which women need treatment for cervical changes. It is for women who have had an abnormal Pap smear or a positive HPV test and are going for a colposcopy (a closer look at the cervix).
This trial studies a “conservative” (less immediate) approach to a specific abnormal cervix finding to see if it can be managed safely for people who want future pregnancies. It uses close follow-up visits instead of immediate procedures for certain results.
This study watches to see if early precancerous cells (CIN 2 or 3) on the cervix can go away without treatment, especially in women under 40. It helps doctors understand who might avoid surgery.
This trial tests a light-activated therapy (called HAL-PDT) for a specific type of abnormal cervical cell change known as CIN2. It aims to see if this treatment can destroy the abnormal cells while keeping the cervix healthy, potentially avoiding surgery.
Hear when a new HPV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.